• B-Cell Non-Hodgkin Lymphoma Pipeline 2025: Therapies Under openPR.com Wed, 30 Apr 2025 20:42:00 GMT
• Oncternal Therapeutics (NASDAQ:ONCT) Earns Hold Rating from Analysts at StockNews.com Defense World Mon, 28 Apr 2025 06:32:18 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Sun, 20 Apr 2025 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated at stocknews.com The AM Reporter Mon, 14 Apr 2025 05:32:45 GMT
• Oncternal Therapeutics (NASDAQ:ONCT) Now Covered by Analysts at StockNews.com Defense World Sat, 12 Apr 2025 07:00:00 GMT
• chronic lymphocytic leukemia pipeline analysis and clinical openPR.com Tue, 08 Apr 2025 07:00:00 GMT
• Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated by Analysts at StockNews.com Defense World Fri, 04 Apr 2025 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Thu, 27 Mar 2025 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com The AM Reporter Thu, 20 Mar 2025 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Wed, 19 Mar 2025 09:25:40 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Tue, 11 Mar 2025 07:00:00 GMT
• future industry growth of metastatic prostate cancer market openPR.com Mon, 10 Mar 2025 07:00:00 GMT
• Oncternal Therapeutics Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC GlobeNewswire Fri, 07 Mar 2025 08:00:00 GMT
• From Nasdaq to Dark: What's Next for Oncternal After March 2025 Delisting? Stock Titan Fri, 07 Mar 2025 08:00:00 GMT
• b-cell non-hodgkin lymphoma pipeline 2024: moa, roa, and clinical trial insights explored by delveinsight | biegene, oncternal the... Barchart Wed, 05 Mar 2025 21:51:14 GMT
• ewing sarcoma clinical trials and studies: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and companies The Globe and Mail Mon, 03 Mar 2025 16:31:03 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Mon, 03 Mar 2025 07:20:23 GMT
• oncternal therapeutics (onct) expected to announce quarterly earnings on thursday Defense World Thu, 27 Feb 2025 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Sun, 23 Feb 2025 11:14:39 GMT
• marginal zone lymphoma clinical trials and studies: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and companies The Globe and Mail Wed, 19 Feb 2025 18:56:56 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Sat, 15 Feb 2025 06:13:01 GMT
• billionaire investor david tepper doubles down on these stocks. should you follow? The Globe and Mail Wed, 12 Feb 2025 08:00:00 GMT
• metastatic prostate cancer clinical and non-clinical studies, openPR Mon, 10 Feb 2025 16:11:00 GMT
• oncternal therapeutics (nasdaq:onct) earns hold rating from analysts at stocknews.com Defense World Mon, 10 Feb 2025 08:00:00 GMT
• head-to-head survey: oncternal therapeutics (nasdaq:onct) & organigram (nasdaq:ogi) Defense World Mon, 03 Feb 2025 06:25:27 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated at stocknews.com Defense World Thu, 30 Jan 2025 08:00:00 GMT
• ONCT stock price: Oncternal stock crashes by 60% after layoffs Markets.com Thu, 23 Jan 2025 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) earns hold rating from analysts at stocknews.com Defense World Wed, 22 Jan 2025 08:00:00 GMT
• ibm stock 2025 outlook: can ai and cloud revive ibm’s growth? The Globe and Mail Tue, 14 Jan 2025 08:00:00 GMT
• stocknews.com begins coverage on oncternal therapeutics (nasdaq:onct) Defense World Tue, 14 Jan 2025 08:00:00 GMT
• ewing sarcoma clinical trials 2024: ema, pdma, fda approvals, openPR Mon, 06 Jan 2025 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Mon, 06 Jan 2025 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) now covered by analysts at stocknews.com Defense World Sun, 29 Dec 2024 07:45:38 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated at stocknews.com Defense World Sat, 21 Dec 2024 08:00:00 GMT
• oncternal therapeutics to participate in the h.c. wainwright 24th annual global investment conference Marketscreener.com Thu, 19 Dec 2024 13:30:01 GMT
• celu - celularity inc. latest stock news & market updates StockTitan Tue, 10 Dec 2024 18:09:48 GMT
• 'fresh-in, fresh-out' dual-targeted car t-cell therapy shows promise in phase ii dlbcl trial Precision Medicine Online Sun, 08 Dec 2024 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Thu, 05 Dec 2024 08:00:00 GMT
• onct stock touches 52-week low at $0.61 amid market challenges Investing.com Mon, 02 Dec 2024 08:00:00 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Wed, 27 Nov 2024 09:50:32 GMT
• onct stock touches 52-week low at $0.83 amid market challenges Investing.com Tue, 26 Nov 2024 04:39:51 GMT
• onct stock touches 52-week low at $0.83 amid market challenges Investing.com India Mon, 25 Nov 2024 08:00:00 GMT
• oncternal shares to be delisted from nasdaq by investing.com Investing.com South Africa Mon, 25 Nov 2024 08:00:00 GMT
• onct (oncternal therapeutics) 9-day rsi : 33.20 (as of nov. 20, 2024) GuruFocus.com Wed, 20 Nov 2024 21:14:16 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Tue, 19 Nov 2024 08:00:00 GMT
• oncternal announces workforce reduction, executive changes Investing.com Sat, 16 Nov 2024 00:04:13 GMT
• oncternal announces workforce reduction, executive changes Investing.com Fri, 15 Nov 2024 08:00:00 GMT
• oncternal therapeutics announces workforce reduction and executive changes TipRanks Thu, 14 Nov 2024 08:00:00 GMT
• onct stock touches 52-week low at $1.03 amid market challenges Investing.com Thu, 14 Nov 2024 06:09:01 GMT
• onct stock touches 52-week low at $1.03 amid market challenges Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• oncternal therapeutics faces workforce reduction challenges: potential risks and implications TipRanks Fri, 08 Nov 2024 06:04:04 GMT
• phase 1/2 trial of onct-534 in mcrpc has been terminated Urology Times Thu, 07 Nov 2024 08:00:00 GMT
• oncternal therapeutics faces workforce reduction challenges: potential risks and implications TipRanks Thu, 07 Nov 2024 08:00:00 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Sun, 03 Nov 2024 06:13:40 GMT
• oncternal therapeutics, inc. announces updated safety and efficacy data for phase 1/2 study of onct-534 for the treatment of r/r m... Marketscreener.com Wed, 30 Oct 2024 14:27:29 GMT
• oncternal therapeutics announces updated data from phase 1/2 study of onct-534 TipRanks Tue, 22 Oct 2024 13:07:06 GMT
• oncternal reports positive prostate cancer treatment results by investing.com Investing.com UK Tue, 22 Oct 2024 07:00:00 GMT
• oncternal therapeutics announces updated safety and efficacy data for phase 1/2 study of onct-534 for the treatment of r/r metasta... GlobeNewswire Tue, 22 Oct 2024 07:00:00 GMT
• onct-534 reduces psa levels, is tolerable in relapsed/refractory mcrpc OncLive Tue, 22 Oct 2024 07:00:00 GMT
• b-cell non-hodgkin lymphoma pipeline assessment 2024: therapies, clinical trials, and growth prospects | biegene, oncternal therap... Barchart Fri, 18 Oct 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated at stocknews.com Defense World Fri, 18 Oct 2024 06:21:41 GMT
• onct stock touches 52-week low at $1.19 amid market challenges Investing.com Australia Fri, 11 Oct 2024 08:00:34 GMT
• oncternal therapeutics inc (onct) q2 2024 earnings call highligh GuruFocus Wed, 09 Oct 2024 07:00:00 GMT
• onct stock touches 52-week low at $1.19 amid market challenges Investing.com Wed, 09 Oct 2024 07:00:00 GMT
• onct stock touches 52-week low at $1.31 amid market challenges Investing.com Australia Tue, 01 Oct 2024 01:14:24 GMT
• onct stock touches 52-week low at $1.31 amid market challenges Investing.com Mon, 30 Sep 2024 07:00:00 GMT
• recent research analysts’ ratings changes for oncternal therapeutics (onct) Defense World Fri, 27 Sep 2024 07:00:00 GMT
• layoff tracker: bluebird bio to cut 25% of workforce and more news BioSpace Wed, 25 Sep 2024 07:00:00 GMT
• dr. nickols on phase 2 solar trial of multimodal therapy in prostate cancer Urology Times Tue, 24 Sep 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) now covered by analysts at stocknews.com Defense World Tue, 24 Sep 2024 06:18:11 GMT
• onconetix, inc. announces 1-for-40 reverse stock split and results of the annual meeting of stockholders GlobeNewswire Fri, 20 Sep 2024 15:45:54 GMT
• investors watch key players in oncology as cancer cases set to skyrocket Baystreet.ca Fri, 20 Sep 2024 15:07:58 GMT
• investors who lost money on outset medical, inc. (om) should contact levi & korsinsky about pending class action - om GlobeNewswire Thu, 19 Sep 2024 17:39:48 GMT
• oncolytics biotech (nasdaq:oncy) stock rating reaffirmed by hc wainwright MarketBeat Thu, 19 Sep 2024 16:55:32 GMT
• recent breakthroughs in cancer research could impact these key companies Baystreet.ca Thu, 19 Sep 2024 15:52:14 GMT
• oncolytics biotech® reports favorable results for bracelet-1 breast cancer study reinforcing path to funding of a registration-ena... PR Newswire Thu, 19 Sep 2024 11:00:00 GMT
• is on holding ag's (nyse:onon) recent stock performance tethered to its strong fundamentals? Simply Wall St Thu, 19 Sep 2024 10:26:14 GMT
• on (nyse:onon) given new $59.00 price target at stifel nicolaus Defense World Thu, 19 Sep 2024 08:49:48 GMT
• biopharma layoff tracker 2024: agc biologics, oncternal, biosense webster and more cut staff BioSpace Thu, 19 Sep 2024 07:00:00 GMT
• on (nyse:onon) reaches new 1-year high after analyst upgrade Defense World Thu, 19 Sep 2024 05:08:48 GMT
• on holding ag shares get price target boost, buy rating from stifel Investing.com Wed, 18 Sep 2024 16:16:16 GMT
• investing in on holding ag (onon) is getting more attractive Knox Daily Wed, 18 Sep 2024 14:54:53 GMT
• on (nyse:onon) hits new 1-year high after analyst upgrade MarketBeat Wed, 18 Sep 2024 14:26:48 GMT
• does on holding (nyse:onon) deserve a spot on your watchlist? Yahoo Finance Wed, 18 Sep 2024 10:55:14 GMT
• around the helix: cell and gene therapy company updates – september 18, 2024 CGTLive™ Wed, 18 Sep 2024 07:00:00 GMT
• on holding ag: -0.15% growth from 52-week low, yet analysts divided The InvestChronicle Tue, 17 Sep 2024 20:24:09 GMT
• understanding onon’s financial ratios: a beginner’s guide US Post News Tue, 17 Sep 2024 18:18:30 GMT
• private advisor group llc purchases 7,154 shares of on holding ag (nyse:onon) Defense World Tue, 17 Sep 2024 11:51:12 GMT
• investor’s delight: on holding ag (onon) closes weak at 48.63, down -0.86 The Dwinnex Mon, 16 Sep 2024 18:09:22 GMT
• biopharma layoff tracker 2024: oncternal, biosense webster, charles river laboratories and more cut staff BioSpace Mon, 16 Sep 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Mon, 16 Sep 2024 06:21:07 GMT
• Oncternal Therapeutics Axes B-Cell Lymphoma Trial for CAR-T Therapy ONCT-808 CGTLive® Sun, 15 Sep 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) downgraded by northland capmk Defense World Sun, 15 Sep 2024 05:43:36 GMT
• td asset management inc invests $1.52 million in on holding ag (nyse:onon) Defense World Sat, 14 Sep 2024 10:56:55 GMT
• analyzing the impact of earnings reports on oncternal therapeutics inc inc. (onct) price performance The InvestChronicle Fri, 13 Sep 2024 11:50:29 GMT
• in the green: oncternal therapeutics inc (onct) closes at 1.70, up/down -59.09 from previous day The Dwinnex Fri, 13 Sep 2024 11:04:46 GMT
• Oncternal stock crashes by 60% as it lays off staff and scraps trials Clinical Trials Arena Fri, 13 Sep 2024 07:00:00 GMT
• north american morning briefing : stock futures -2- Marketscreener.com Fri, 13 Sep 2024 07:00:00 GMT
• oncternal therapeutics announces workforce reduction and trial discontinuations by investing.com Investing.com Australia Fri, 13 Sep 2024 07:00:00 GMT
• director wills robert james acquire 3,086 shares of oncternal therapeutics inc [onct] Knox Daily Fri, 13 Sep 2024 07:00:00 GMT
• Oncternal folds all clinical trials after lackluster data drop, patient death Fierce Biotech Thu, 12 Sep 2024 07:00:00 GMT
• Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives GlobeNewswire Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics ends development activities, mulls options MarketWatch Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics cuts jobs, discontinues product development amid business review MarketWatch Thu, 12 Sep 2024 07:00:00 GMT
• oncternal stock plunges on portfolio shakeup (nasdaq:onct) Seeking Alpha Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics downgraded to market perform from outperform at northland TipRanks Thu, 12 Sep 2024 07:00:00 GMT
• onct stock touches 52-week low at $1.7 amid market challenges Investing.com India Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics announces workforce reduction and trial discontinuations Investing.com Thu, 12 Sep 2024 07:00:00 GMT
• oncternal halts trials for cancer treatments, seeks alternatives Investing.com Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) earns hold rating from analysts at stocknews.com Defense World Sat, 31 Aug 2024 06:16:11 GMT
• oncternal therapeutics (nasdaq:onct) research coverage started at stocknews.com Defense World Fri, 23 Aug 2024 06:43:56 GMT
• onct (oncternal therapeutics) financial strength : 8 (as of jun. 2024) GuruFocus.com Sat, 17 Aug 2024 15:45:18 GMT
• oncternal therapeutics (nasdaq:onct) earns hold rating from analysts at stocknews.com Defense World Thu, 15 Aug 2024 08:03:26 GMT
• oncternal therapeutics (nasdaq:onct) pt lowered to $18.00 at hc wainwright Defense World Mon, 12 Aug 2024 12:35:26 GMT
• oncternal therapeutics second quarter 2024 earnings: beats expectations Yahoo Finance Sun, 11 Aug 2024 13:51:17 GMT
• oncternal therapeutics, inc. (onct) q2 2024 earnings call transcript Seeking Alpha Sat, 10 Aug 2024 05:46:01 GMT
• oncternal therapeutics price target lowered to $18 from $19 at h.c. wainwright TipRanks Fri, 09 Aug 2024 07:00:00 GMT
• onct stock earnings: oncternal therapeutics beats eps, beats revenue for q2 2024 InvestorPlace Fri, 09 Aug 2024 01:09:26 GMT
• oncternal therapeutics (onct) reports q2 loss, tops revenue estimates Yahoo Finance Thu, 08 Aug 2024 21:30:11 GMT
• oncternal therapeutics (nasdaq:onct) stock, analyst ratings, price targets, forecasts Benzinga Thu, 08 Aug 2024 20:08:00 GMT
• oncternal therapeutics provides business update and announces second quarter 2024 financial results Yahoo Finance Thu, 08 Aug 2024 07:00:00 GMT
• oncternal therapeutics: q2 earnings snapshot San Francisco Chronicle Thu, 08 Aug 2024 07:00:00 GMT
• oncternal therapeutics reports q2 eps ($2.89 ), consensus ($3.10) TipRanks Thu, 08 Aug 2024 07:00:00 GMT
• oncternal therapeutics (onct) scheduled to post quarterly earnings on thursday Defense World Wed, 07 Aug 2024 11:52:34 GMT
• oncternal therapeutics (nasdaq:onct) now covered by stocknews.com Defense World Wed, 07 Aug 2024 05:42:37 GMT
• oncternal therapeutics to provide business update and report second quarter 2024 financial results GlobeNewswire Thu, 01 Aug 2024 20:06:26 GMT
• oncternal therapeutics (nasdaq:onct) now covered by stocknews.com Defense World Tue, 30 Jul 2024 07:00:00 GMT
• hc wainwright reiterates buy rating for oncternal therapeutics (nasdaq:onct) Defense World Tue, 16 Jul 2024 22:12:03 GMT
Oncternal Therapeutics, Inc(NASDAQ:ONCT) 
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical need. Its pipeline includes cirmtuzumab, an investigational monoclonal antibody that is being evaluated in a Phase 1/2 clinical trial in ...
Website: http://www.oncternal.com
Founded: 1997
Full Time Employees: 11
CEO: James B. Breitmeyer
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends